General Information of the Compound
Compound ID
CP0382510
Compound Name
7-(1,2-benzothiazol-3-yl)-9-methoxy-4-(pyridin-3-ylmethyl)-3,5-dihydro-2H-1,4-benzoxazepine
    Show/Hide
Structure
Formula
C23H21N3O2S
Molecular Weight
403.507
Canonical SMILES
COc1cc(cc2CN(Cc3cccnc3)CCOc12)-c1nsc2ccccc12
    Show/Hide
InChI
InChI=1S/C23H21N3O2S/c1-27-20-12-17(22-19-6-2-3-7-21(19)29-25-22)11-18-15-26(9-10-28-23(18)20)14-16-5-4-8-24-13-16/h2-8,11-13H,9-10,14-15H2,1H3
    Show/Hide
InChIKey
QKTRVVYVLRGLMM-UHFFFAOYSA-N
Physicochemical Property
logP
4.7615
Rotatable Bonds
4
Heavy Atom Count
29
Polar Areas
47.48
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 122180272
ChEMBL ID
CHEMBL3586335
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00948, Prostaglandin E2 receptor EP2 subtype
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000516 ECV-304 Homo sapiens (Human)  2
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
2
IC50 = 600 nM
   TI
   LI
   LO
   TS